Pembrolizumab and Ipilimumab as Second-Line Therapy for Advanced Melanoma. Huppert LA, Daud AI. J Clin Oncol 2021 Jun 17:JCO2100943. doi: 10.1200/JCO.21.00943.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Huppert LA, Daud AI. Pembrolizumab and Ipilimumab as Second-Line Therapy for Advanced Melanoma. J Clin Oncol 2021 Jun 17:JCO2100943. doi: 10.1200/JCO.21.00943.
PMID: 34138634